EP3773589
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.4.2019EP published:
1.11.2023EP application number:
19718531.7
EPO information:
European Patent Register
Max expiry date:
2.4.2039
Title in English:
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATIONLanguage of the patent:
English
Timeline
Today
3.4.2019EP application
1.11.2023EP Publication
Owner
Name:
Blueprint Medicines CorporationAddress:
45 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
EVANS RAAB, EricaAddress:
Cambridge, Massachusetts 02139, US
Name:
WOLF, Beni B.Address:
Cambridge, Massachusetts 02139, US
Priority
Number:
201862652284 PDate:
3.4.2018Country:
US
Number:
201862656297 PDate:
11.4.2018Country:
US
Number:
201862657605 PDate:
13.4.2018Country:
US
Number:
201862741683 PDate:
5.10.2018Country:
US
Classification
Categories:
A61K 31/506, A61K 45/06, A61P 35/04, A61P 35/00